End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,420 KRW | -2.80% | -6.38% | +53.91% |
Business Summary
Number of employees: 376
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Non-clinical Laboratory Agency Services
95.1
%
| 41,284 | 89.2 % | 32,017 | 95.1 % | -22.45% |
Cell Therapy Drugs
4.9
%
| 5,009 | 10.8 % | 1,640 | 4.9 % | -67.26% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 46,293 | 100.0 % | 33,657 | 100.0 % | -27.30% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gyeong-Sook Kim
CEO | Chief Executive Officer | 59 | - |
Tae-Yong Lee
CTO | Chief Tech/Sci/R&D Officer | 42 | - |
Heon-Jeong Lim
AUD | Comptroller/Controller/Auditor | 56 | - |
Gil-Ahn Yang
SAM | Sales & Marketing | 68 | 18-06-30 |
Gwang-Soon Kwon
PRN | Corporate Officer/Principal | 52 | 17-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gyeong-Sook Kim
CEO | Chief Executive Officer | 59 | - |
Kwan-Hee Hong
BRD | Director/Board Member | 65 | 18-02-28 |
Sang-Bae Han
BRD | Director/Board Member | 59 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,870,376 | 17,454,843 ( 53.10 %) | 11,460,416 ( 34.87 %) | 53.10 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CORESTEMCHEMON INC. 23.78% | 7,817,638 | 23.78% | 65,217,707 $ |
Company contact information
CORESTEMCHEMON, Inc.
2/F, I & C Building 24 Pangyo-ro 255 beon-gil
13486, Seongnam-si
+
http://www.corestem.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+53.91% | 168M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- A166480 Stock
- Company CORESTEMCHEMON Inc.